Brainstorm Cell Therapeutics | 8-K: Current report
Brainstorm Cell Therapeutics | 8-K: Current report
Brainstorm Cell Therapeutics | 8-K: Current report
Brainstorm Cell Therapeutics | 8-K: Current report
Brainstorm Cell Therapeutics | 8-K: Current report
Brainstorm Cell Therapeutics | 8-K: Current report
Brainstorm Cell Therapeutics | 8-K: Current report
Brainstorm Cell Therapeutics | 8-K: Current report
Brainstorm Cell Therapeutics | DEFA14A: Others
Brainstorm Cell Therapeutics | 8-K: Current report
Brainstorm Cell Therapeutics | 8-K: BrainStorm Cell Therapeutics Announces Third quarter 2023 Financial Results and Provides Corporate Update
Brainstorm Cell Therapeutics | 8-K: Current report
Brainstorm Cell Therapeutics | DEF 14A: Definitive information statements
Brainstorm Cell Therapeutics | 8-K: Current report
Brainstorm Cell Therapeutics | 8-K: Current report
Brainstorm Cell Therapeutics | 8-K: BrainStorm Cell Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update
Brainstorm Cell Therapeutics | 8-K: Current report
Brainstorm Cell Therapeutics | 8-K: Current report
Brainstorm Cell Therapeutics | 8-K: Current report
Brainstorm Cell Therapeutics | 8-K: Current report
No Data